The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.